




版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡介
利尿藥和降血糖藥Medicinalchemistry利尿藥和降血糖藥Chapter10Diureticsand
SyntheticHypoglycemicDrugsSection1HypoglycemicDrugsSection2Diuretics利尿藥和降血糖藥Section1
HypoglycemicDrugsTheclassictriadofsymptomsindiabetesispolyphagia,polydypsia(thirst),andpolyuria(excessurine).Allthreeresultdirectlyfromexcessiveserumglucoselevels.Type1diabetesusuallydevelopsinanacutemanner,althoughthedestructiveautoimmuneprocessmayhavebeenunderwayforsometime.Type2diabeteshasamoreinsidious,oftenasymptomaticonsetanditspresenceisusuallydetectedbyroutinemedicalexaminations.利尿藥和降血糖藥Definitions
TypeIDiabetes.Insulin-dependentdiabetesmellitus(IDDM),thisconditionoccurswhentheβ-cellsofthepancreaticisletsofLangerhansaredestroyed,probablybyanautoimmuneprocess,suchthatinsulinproductionisdeficient.Type2Diabetes.Noninsulin-dependentdiabetesmellitus(NIDDM)isveryfrequentlyassociatedwithobesityinitsmainlyadultvictims.Seruminsulinlevelsarenormalorelevated,soinessencethisisadiseaseofinsulinresistance.利尿藥和降血糖藥BiochemistryandPathogenesisofDiabetes利尿藥和降血糖藥ClassificationsFirstGenerationSulfonylureas:tolbutamide.SecondGenerationSulfonylureas:glibenclamide.ThirdGenerationSulfonylureas:glimepiride,repaglinide.Biguanides:metformin.α-GlucosidaseInhibitors:Acarbose,Miglitol.利尿藥和降血糖藥
MechanismofActionSulfonylureasinteractwithreceptorsonpancreaticβ-cellstoblockATP-sensitivepotassiumchannels.Thisinturnleadstoopeningofvoltage-sensitivecalciumchannelswhichproducesaninfluxofcalcium;theinfluxofcalciumresultsinβ-cellsproductionofinsulin.Anadditionaleffectofsulfonylureasissuppressionofgluconeogenesisintheliver.利尿藥和降血糖藥
Physical-ChemicalPropertiesSulfonylureasareweakacidsduetothemarkeddelocalizationofthenitrogenloneelectronpairbythesulfonylgroup.TheirpKa'sclusteraround5.0andtheyarestronglyproteinbound.利尿藥和降血糖藥
Structure-activityRelationshipsTheremustbereasonablebulkontheureanitrogen;methylandethylcompoundsarenotactive.Usually,thereisonlyone(normallysubstituentpara)onthesulfonylaromaticring.利尿藥和降血糖藥Manysimplesubstituentsonthesulfonylaromaticringareactive.Thep-(β-arylcarboxamidoethyl)groupingseeninsecondgenerationcompoundsisconsistentwithhighpotency.Itisthoughtthatthespatialrelationshipbetweentheamidenitrogenofthesubstituentandthesulfonamidenitrogenisimportant.利尿藥和降血糖藥
TolbutamideN-[(Butylamino)carbonyl]-4-methylbenzene–sulfonamideButylgroupontheureanitrogen;Para-methylbenzeneonthesulfonylgroup.利尿藥和降血糖藥
Properties
Tolbutamidehavesulfonylureastructurewithweakacid,andthispropertymaybeusedforassay.利尿藥和降血糖藥Instability:Tolbutamideishydrolyzedtopara-toluenesulfonamidebyacids.Heatingofitsfiltratewithsodiumhydroxidesolutionproducesn-butylamineodour.利尿藥和降血糖藥Metabolism
Tolbutamideismetabolizedinthelivertop-hydroxyltolbutamide,retainingabout35%oftheactivityoftheparentcompound.itisconvertedveryrapidlytotheinactivetolbutamide4-carboxylicacid.利尿藥和降血糖藥Glibenclamide5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]-2-methoxybenzamideIntroductionofcyclohexaneontheureanitrogen;Introductionofsidechainonthesulfonylaromaticring.
利尿藥和降血糖藥Properties
Itisnotstabletomoistureandishydrolyzedtosulfamidederivate.利尿藥和降血糖藥MetabolismGlibenclamideaffordstrans-4'-hydroxy-glyburideasthemajorproduct.The3'-hydroxymetaboliteretainsabout15%oftheactivityoftheparentcompound.利尿藥和降血糖藥TherapeuticApplicationIngeneral,theeffectsofthefirst-andsecond-generationsulfonylureasaresimilar.Allproducereliablehypoglycemiaintype2diabetics.Theseagentsworkbestinpatientswhosetype2diabetesisrelativelymild.利尿藥和降血糖藥SyntheticRoute利尿藥和降血糖藥Third-generationsulfonylureaGlimepirideisasulfonylureawithaquickonsetofactionandalongdurationofaction.Itmaybindtoadifferentproteinintheputativesulfonylureareceptorthanearlierdrugs,andmayexertitshypoglycemiceffectwithlesssecretionofinsulin.利尿藥和降血糖藥
Metforminhydrochloride
N,N-DimethylimidodicarbonimidicdiamidehydrochlorideMetformin,Biguanides,hasbeeninusethroughouttheworld,withtheexceptionoftheU.S.,fordecades.利尿藥和降血糖藥
MechanismofActionMetforminisusuallysaidtobeanantihyperglycemicratherthanahypoglycemicagent.Overall,thedrugappearstoincreaseglucoseutilization.Inhibitionofgluconeogenesisappearstobeanimportantcomponentofthedrug'sactivity.利尿藥和降血糖藥
ActionsandUsesUnlikesulfonylureas,Metforminisnotproteinbound,isnotmetabolized,andisrapidlyeliminatedbythekidney.Itiswidelyusedasmonotherapyorincombinationwithasulfonylureaintype2diabetes,particularlywhenthepatientisobeseandinsulin-resistant.利尿藥和降血糖藥
α-GlucosidaseInhibitorsTobeabsorbedfromthegastrointestinaltractintothebloodstream,thecomplexcarbohydratesweingestaspartofourdietmustfirstbehydrolyzedtomonosaccharides.Therationalefortheα-glucosidaseinhibitoristhatbypreventingthehydrolysisofcarbohydratestheirabsorptioncouldbereduced.利尿藥和降血糖藥Metabolismofcomplexcarbohydrades
利尿藥和降血糖藥
Section2DiureticsDiureticsarechemicalsthatincreasetherateofurineformation.Diureticusageleadstotheincreasedexcretionofelectrolytes(especiallysodiumandchlorideions)andwaterfromthebodywithoutaffectingprotein,vitamin,glucoseoraminoacidreabsorption.利尿藥和降血糖藥
StructureClassificationThediureticscurrentlyinusetodayareclassifiedasfollows:Thiazides(bytheirchemicalclasses);Carbonicanhydraseinhibitors,osmotics(bymechanismofaction);Loopdiuretics(bysiteofaction);Potassium-sparingdiuretics(byeffectsonurinecontents).利尿藥和降血糖藥Furosemide5-(Aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]benzoicacidFurosemideisanexampleofahigh-ceilingdiureticandmayberegardedasaderivativeofanthranilicacids.利尿藥和降血糖藥
Structure-activityRelationshipsThechlorineandsulfonamidesubstitutionsarefeaturesofthisclassdrugs.Furosemideisastrongeracidthanthethiazidediuretics(pKa3.9).Thisdrugisexcretedprimarilyunchanged.Asmallamountofmetabolism,however,cantakeplaceonthefuranring.利尿藥和降血糖藥
TherapeuticApplicationsFurosemidehasasalureticeffect8-10timesthatofthethiazidediuretics,however,ithasashorterdurationofaction,about6-8hours.Itiseffectiveforthetreatmentofedemasconnectedwithcardiac,hepatic,andrenalsites.Clinicaltoxicityoffurosemideinvolvesabnormalitiesoffluidandelectrolytebalance.利尿藥和降血糖藥Hydrochlorothiazide6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide1,1-dioxideThethiazidediureticsareweaklyacidicwithabenzothiadiaze1,1-dioxidenucleus.利尿藥和降血糖藥
MechanismofActionThemajorsiteofactionofthesecompoundsisinthedistaltubule,wherethesedrugscompeteforthechloridebindingsiteoftheNa+-C1-symporterandinhibitthereabsorptionofsodiumandchlorideions.Theyalsoinhibitthereabsorptionofpotassiumandbicarbonateionsbuttoalesserdegree.利尿藥和降血糖藥
Structure-activityRelationshipThehydrogenatomatthe2-Nisthemostacidic.Theseacidicprotonsmakepossibletheformationofawater-solublesodiumsalt.Anelectron-withdrawinggroupisnecessaryatposition6fordiureticactivity.Replacementorremovalofthesulfonamideatposition7yieldscompoundswithlittleornodiureticactivity.利尿藥和降血糖藥Saturationofthedoublebondtogivea3,4dihydroderivativeproducesadiureticthatis10timesmorethantheunsaturatedderivative.Substitutionlipophilicgroupatposition3givesamarkedinthediureticpotencywithalongerdurationofaction.Alkylsubstitutiononthe2-Npositionalsodecreasesthepolarityandincreasesthedurationofdiureticaction.利尿藥和降血糖藥TherapeuticApplicationsHydrochlorothiazideisindicatedinthemanagementofhypertensioneitherasthesoletherapeuticagent,orincombinationwithotherantihypertensives.利尿藥和降血糖藥AcetazolamideN-[5-(Aminosulfonyl)1,3,4-thiadiazol-2-yl]acetamideAcetazolamidewasthefirstofthecarbonicanhydraseinhibitorswithadiureticeffectthatlastsabout8-12hours.Itisusedprimarilyforthetreatmentofglaucomaandabsenceseizures.利尿藥和降血糖藥MechanismofActionTheactionoftheenzymecarbonicanhydrasecatalyzestheformationofcarbonicacidfromcarbondioxideandwater.Carbonicanhydraseinhibitorsinducediuresisbyinhibitingtheformationofcarbonicacidwithinproximalanddistaltubularcellstolimitthenumberofhydrogenionsavailabletopromotesodiumreabsorption.利尿藥和降血糖藥SpironolactoneTheadrenal(7β-17α)-7(Acetylthio)-17-hydroxy-3-oxopregn-4ene-21-carboxylicacid
-lactone
Spironolactoneisacompetitiveantagonisttothemineralocorticoidssuchasaldosterone.利尿藥和降血糖藥
MechanismofActionTheadrenalcortexsecretesapotentmineralocorticoidcalledaldosteronewhichpromotessaltandwaterretentionandpotassiumandhydrogenionexcretion.Spironolactoneinhibitsreabsorptionofsodiumandchlorideionandincreasedpotassiumionexcretion.利尿藥和降血糖藥
Metabolism
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。
最新文檔
- 就業(yè)趨勢預(yù)測與應(yīng)對考核試卷
- 機(jī)床行業(yè)智能制造與數(shù)字化轉(zhuǎn)型策略分析考核試卷
- 幕墻設(shè)計(jì)與建筑節(jié)能減排考核試卷
- 光學(xué)成像自動(dòng)打樣機(jī)考核試卷
- D打印技術(shù)在工業(yè)自動(dòng)化領(lǐng)域的應(yīng)用考核試卷
- 冷藏車運(yùn)輸企業(yè)運(yùn)營管理優(yōu)化考核試卷
- 勞務(wù)分包員工合同范本
- 買賣鋼材的合同范本
- 毛巾購買合同范本
- 農(nóng)資貨運(yùn)運(yùn)輸合同范本
- 供暖公司環(huán)境因素辨識(shí)與風(fēng)險(xiǎn)評價(jià)表
- 魯濱遜漂流記閱讀任務(wù)單
- 物理聽課記錄物理聽課記錄及評析范文(3篇)
- 華師大版初中數(shù)學(xué)目錄(新)
- 跨國公司的全球經(jīng)營戰(zhàn)略課件
- 管理學(xué)原理(南大馬工程)
- 高考必知的自然科學(xué)類基礎(chǔ)知識(shí)考試題庫(400題)
- 設(shè)計(jì)思維電子課件
- 建筑施工企業(yè)安全生產(chǎn)風(fēng)險(xiǎn)分級管控體系-實(shí)施指南
- 國際貨物運(yùn)輸與保險(xiǎn)課后習(xí)題參考答案
- 房地產(chǎn)銷售培訓(xùn)PPT培訓(xùn)課件
評論
0/150
提交評論